Overview

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Status:
Completed

Trial end date:
2015-09-28

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of PF-05089771 as a monotherapy and as an add-on to pregabalin for the treatment of painful diabetic peripheral neuropathy (DPN)

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer

Treatments:

Pregabalin